SAS - Contract - URGENT START
Job Description
This job involves production of efficacy and safety study reports of data
from clinical studies. The reports (tabulations/listings and graphs) will
form part of the material used in regulatory drug filings. Dependent on the
stage the drug's development, the programmer may also be required to
produce integrated summaries of safety and efficacy. The contract is
initially for 8 months to possibly ongoing. The role includes 2 main areas
* The production and quality control of efficacy study reports written
in SAS. This is achieved by writing and validating software in accordance
with statistical analysis plans and my client programming standards.
* The production and quality control of safety study tables and
listings created by running software within my client's current existing
reporting tool (CDARS).
Both roles would require identification of the general cause of any
reporting issues (e.g. data or programs) and their possible resolution with
data management, programming, statistical or clinical staff as appropriate.
The role may require programming to convert legacy data to my client's data
standards. Training will be given in all my client specific tools and
processes. The successful candidate will be supervised by a lead programmer
who will act as the contact with the main project team.
Person Specification
Essential Criteria - Candidates should meet the following criteria:
* 3+ years of SAS/BASE
* 3+ years of SAS/Macro
* 3+ years of PROC REPORT
* 2 years experience of pharmaceutical data and reporting clinical
trials
* Experience of working closely with a study statistician to discuss
and produce efficacy study reports
* Good communication skills, both written and verbal
* Good time management and planning skills
* Good team working characteristics, capable of working in
cross-functional teams
Desirable Criteria - Preference will be given to candidates who meet the
following criteria:
* Knowledge of reporting clinical trials using my client's reporting
systems
* Knowledge of Software Development Lifecycle (SDLC)
* Knowledge of reporting clinical trials with a Pharms company or CRO
* Knowledge of statistical methodology used to report clinical trials
* Familiar with MS standard packages and windows operating system
* Knowledge of UNIX operating system
* Knowledge of SAS/GRAPH and SAS/SQL
If you are interested in this position, please contact me for review of the
full specification.
If you know of anyone to which this is applicable but may not receive this
email, please feel free to forward this email to relevant persons.
Mathew Hogan
Senior Consultant
Pharmaceutical, Biometrics & CRO Division
1st Pharma People
A Division of 1st-IT People
Tel: +44 (0) 207 255 6665
Fax: +44 (0) 207 255 6656
<mailto:[log in to unmask]>
mailto:[log in to unmask]
<http://www.1st-pharmapeople.com/> www.1st-pharmapeople.com
PLEASE NOTE: As of 31st May 2005 our office address will change to; 1st IT
People, 3rd Floor, Woolverstone House, 61-62 Berners Street, London. W1T
3NJ. As a result of this, we do have a new telephone number of 0207 255
6665. Please note our previous phone number will still work.
Offices in UK, Switzerland, The Netherlands & Hong Kong
This email is confidential and intended solely for the use of the individual
to whom it is addressed. Any views or opinions presented are solely those of
the author and do not represent those of the company from which the email
was sent. If you are not the intended recipient, be advised that you have
received this e-mail in error and that any use, dissemination forwarding,
printing or copying of this e-mail is strictly prohibited. While every
effort has been made to scan this e-mail, we can not accept any
responsibility for the loss of business or damage caused arising from this
email.
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|